Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_assertion type Assertion NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_head.
- NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_assertion description "[To investigate the mechanism(s) of resistance to the RAF-inhibitor vemurafenib, we conducted a comprehensive analysis of the genetic alterations occurring in metastatic lesions from a patient with a BRAF(V600E)-mutant cutaneous melanoma who, after a first response, underwent subsequent rechallenge with this drug.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_provenance.
- NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_assertion evidence source_evidence_literature NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_provenance.
- NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_assertion SIO_000772 23948972 NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_provenance.
- NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_assertion wasDerivedFrom befree-2016 NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_provenance.
- NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_assertion wasGeneratedBy ECO_0000203 NP1102760.RAfMFpb4pnz2yTW4yki3w7rOqfixvF7qML7l-nh1aa9s4130_provenance.